The coronavirus disease 2019 (COVID-19) outbreak remains a major public health
challenge worldwide. The present study investigated the effect of COVID-19 on blood …

This study aims to explore the effect of hypertension on disease progression and prognosis
in patients with coronavirus disease 2019 (COVID-19). A total of 310 patients diagnosed …

Abstract Background Coronavirus disease 2019 (COVID-19) is suspected to mainly be more
deleterious in patients with underlying cardiovascular diseases (CVD). There is a strong …

Coronavirus disease 2019 (COVID-19) has become a worldwide pandemic responsible for
millions of deaths around the world. Hypertension has been identified as one of the most …

Investigations reported that hypertension, diabetes, and cardiovascular diseases were the
most prevalent comorbidities among the patients with coronavirus disease 2019 (COVID …

Hypertension is the single largest global contributor to disability-adjusted life years lost [1].
The majority of the population aged over 60 years have hypertension [2], and it has been …

Introduction: As the coronavirus disease 2019 (COVID-19) outbreak, identification of clinical
predictors of severe or fatal disease are necessary to enable risk stratification and optimize …

Aims It remains unknown whether the treatment of hypertension influences the mortality of
patients diagnosed with coronavirus disease 2019 (COVID-19). Methods and results This is …

Coronavirus disease (COVID-19) is a novel infectious disease caused by a newly
discovered severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)[1, 2]. COVID-19 …

Background COVID-19 is a respiratory infectious disease caused by SARS-CoV-2, and
cardiovascular damage is commonly observed in affected patients. We sought to investigate …